Placental Growth Factor Mediates Mesenchymal Cell Development, Cartilage Turnover, and Bone Remodeling During Fracture Repair.
From: Laboratory of Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium.
The Journal of clinical investigation
- Publish Date: May 2006
- ISSN: 0021-9738
- Volume: 116
- Issue: 5
- Pages: 1230-42
- Medium: Print
- Language: English
- Citation (JAMA): Maes Christa, Coenegrachts Lieve, Stockmans Ingrid, et al. Placental Growth Factor Mediates Mesenchymal Cell Development, Cartilage Turnover, and Bone Remodeling During Fracture Repair.. J. Clin. Invest. May 2006;116:1230-42
Abstract
Current therapies for delayed- or nonunion bone fractures are still largely ineffective. Previous studies indicated that the VEGF homolog placental growth factor (PlGF) has a more significant role in disease than in health. Therefore we investigated the role of PlGF in a model of semi-stabilized bone fracture healing. Fracture repair in mice lacking PlGF was impaired and characterized by a massive accumulation of cartilage in the callus, reminiscent of delayed- or nonunion fractures. PlGF was required for the early recruitment of inflammatory cells and the vascularization of the fracture wound. Interestingly, however, PlGF also played a role in the subsequent stages of the repair process. Indeed in vivo and in vitro findings indicated that PlGF induced the proliferation and osteogenic differentiation of mesenchymal progenitors and stimulated cartilage turnover by particular MMPs. Later in the process, PlGF was required for the remodeling of the newly formed bone by stimulating osteoclast differentiation. As PlGF expression was increased throughout the process of bone repair and all the important cell types involved expressed its receptor VEGFR-1, the present data suggest that PlGF is required for mediating and coordinating the key aspects of fracture repair. Therefore PlGF may potentially offer therapeutic advantages for fracture repair.
Mesh Headings (Keywords): Animals, Bone Remodeling, Cartilage, Cell Differentiation, Cell Proliferation, Fracture Healing, Inflammation, Mesoderm, Mice, Mice, Transgenic, Models, Biological, Osteoclasts, Pregnancy Proteins, Vascular Endothelial Growth Factor Receptor-1
Check for Full Text / PubMed Unique Identifier (PMID): 16614757
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.